关于用于神经退行性疾病治疗的PROTACs的研究进展
Zhifang Cai1, Zunhua Yang1, Huilan Li2
1College of Pharmacy, Jiangxi University of Chinese Medicine, Nanchang 330004, China.
Bioorganic chemistry
|April 21, 2024
概括
针对蛋白质分解的嵌合体 (PROTACs) 通过降解错误折叠的蛋白质,为神经退行性疾病 (NDD) 提供了一种新的治疗策略. 需要进一步的研究,以将PROTACs从临床前阶段推向临床阶段,用于NDD治疗.
科学领域:
- 神经科学是一个神经科学.
- 生物化学 生物化学
- 药理学 药理学是指药理学的学科.
背景情况:
- 神经退行性疾病 (NDD) 涉及神经元恶化和蛋白质错折,治疗选择有限.
- 异常的蛋白质聚合是NDD的关键病理特征,如阿尔茨海默病,帕金森病和亨廷顿病.
研究的目的:
- 审查针对蛋白质溶解的嵌合体 (PROTACs) 结构和神经退行性疾病 (NDD) 治疗的生物活动.
- 从2016年到现在为NDD提供基于PROTAC的干预措施的最新概述.
主要方法:
- 汇编和分析报告的PROTAC结构及其针对NDD的生物活动.
- 在神经退行性疾病研究中对PROTAC应用的文献综述.
主要成果:
- PROTACs利用无素-蛋白酶系统以催化降解异常蛋白质,包括那些被认为是"不可抗药"的蛋白质.
- 该审查汇编了与NDD相关的PROTAC结构和活动,突出了它们对精确蛋白质水平控制的潜力.
结论:
- PROTACs代表了神经退行性疾病的有希望的治疗途径,提供了一种针对错误折叠的蛋白质的新方法.
- 虽然大多数NDD的PROTAC正在临床前研究中,但克服口服生物可用性和血脑屏障透性等挑战对于临床进展至关重要.
相关概念视频
Parkinson's Disease: Overview
541
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
541
Enzyme-linked Receptors
78.3K
Enzyme-linked receptors are proteins that act as both receptor and enzyme, activating multiple intracellular signals. This is a large group of receptors that include the receptor tyrosine kinase (RTK) family. Many growth factors and hormones bind to and activate the RTKs.
Neurotrophin (NT) receptors are a family of RTKs, including trkA, trkB, and trkC (tropomyosin-related kinase) receptors. TrkA is specific for nerve growth factor (NGF), neurotrophin-6, and neurotrophin-7. TrkB binds...
Neurotrophin (NT) receptors are a family of RTKs, including trkA, trkB, and trkC (tropomyosin-related kinase) receptors. TrkA is specific for nerve growth factor (NGF), neurotrophin-6, and neurotrophin-7. TrkB binds...
78.3K


